Document is current
Any future updates will be listed below
-
Authors
Li, Kan https://orcid.org/0000-0002-0825-1934
Rudy, Michael J.
Klose, Thomas https://orcid.org/0000-0002-2150-9792
Tan, Haozhou
Wu, Xiangmeng
Demssie, Hiwot A.
Anderson, Jacqueline S.
Jadhav, Prakash
Zhang, Qing-Yu
Clarke, Penny
Kuhn, Richard J. https://orcid.org/0000-0003-4148-1026
Tyler, Kenneth L. https://orcid.org/0000-0003-3294-5888
Wang, Jun https://orcid.org/0000-0002-4845-4621
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI157046)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI147325)
- License Information
-
More Information
Article History
Received: 28 August 2025
Accepted: 28 January 2026
First Online: 10 February 2026
Competing interests
: Rutgers, the State University of New Jersey, has applied for a provisional patent that covers the VP1 inhibitors reported in this manuscript and related compounds. The inventors include K.L. and J.W. The remaining authors declare that they have no competing interests.
